Paper9749478
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
D'Amico AV and 10 others. JAMA, 1998. Cited by 3,731 papers, by iCite.
Cite this record
ConductScience Library. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Papers, record 9749478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9749478
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Prostate-Specific Antigen | Major topic |
| Prostatic Neoplasms | Major topic |
| Antineoplastic Agents, Hormonal | |
| Brachytherapy | |
| Chemotherapy, Adjuvant | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Multivariate Analysis | |
| Neoplasm Staging | |
| Proportional Hazards Models | |
| Prostatectomy | |
| Radiotherapy Dosage | |
| Retrospective Studies | |
| Survival Analysis |
Source PubMed
Trials12
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00693238 | Proton Therapy for Low and Intermediate Risk Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT01040624 | Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT01368055 | Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT01655836 | High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT01848067 | Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT02156414 | Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT03255135 | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | Background | ClinicalTrials.gov | |
| NCT03289221 | Effects of High-Intensity Focused Ultrasound (HIFU) Treatment on Fecal Continence and Anorretal Fisiology | Results | ClinicalTrials.gov | |
| NCT03829930 | Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer | Background | ClinicalTrials.gov | |
| NCT03864939 | Application of Dried Human Amnion Graft to Improve Postprostatectomy Incontinence and Potency | Background | ClinicalTrials.gov | |
| NCT04261777 | Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients | Background | ClinicalTrials.gov | |
| NCT06798558 | Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy | Background | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 9749485 | Comparing treatments for localized prostate cancer--persisting uncertainty. | https://conductscience.org/library/papers/9749485 | PubMed |
| Comment in | 10235143 | Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. | https://conductscience.org/library/papers/10235143 | PubMed |
| Comment in | 10235144 | Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. | https://conductscience.org/library/papers/10235144 | PubMed |
| Comment in | 10235145 | Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. | https://conductscience.org/library/papers/10235145 | PubMed |
| Comment in | 10235146 | Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. | https://conductscience.org/library/papers/10235146 | PubMed |
Cited by1,682
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,731 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42982989 | Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42982989 | PubMed |
| 42955349 | Implementation of the HUGO™ RAS system for robot-assisted radical prostatectomy: a single-center comparison with the da Vinci Xi® system. | World J Urol | 2026 | https://conductscience.org/library/papers/42955349 | PubMed |
| 42922617 | Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer. | medRxiv | 2026 | https://conductscience.org/library/papers/42922617 | PubMed |
| 42903118 | Prognostic value of postoperative dynamic PNI trajectories for biochemical recurrence in patients with high-risk localized prostate cancer: a longitudinal trajectory clustering study. | Front Nutr | 2026 | https://conductscience.org/library/papers/42903118 | PubMed |
| 42871139 | Personalized Boolean network dynamic profiling and machine learning approaches to identify combinatorial treatments for prostate cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42871139 | PubMed |
| 42866815 | Comparative outcomes of radical prostatectomy, radiotherapy, and radiotherapy plus androgen deprivation therapy for high-risk and very high-risk prostate cancer: a narrative review. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42866815 | PubMed |
| 42861175 | Artificial intelligence-based prostate cancer risk stratification via large-scale ultrasound images paired with histopathology. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42861175 | PubMed |
| 42829772 | Incidence, Patterns, and Predictive Factors of Biochemical Failure Following Definitive Radiotherapy for Localized Prostate Cancer: A Retrospective Military Cohort Study. | Cureus | 2026 | https://conductscience.org/library/papers/42829772 | PubMed |
| 42821058 | Baseline Ga-68 PSMA PET/CT-derived volumetric parameters as predictors of biochemical recurrence following radical prostatectomy. | Ann Nucl Med | 2026 | https://conductscience.org/library/papers/42821058 | PubMed |
| 42802268 | Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42802268 | PubMed |
| 42781078 | Validation of Comprehensive Prostate Cancer Assessment on Sexual Health for Men Who Have Sex With Men (COMPASS). | JU Open Plus | 2026 | https://conductscience.org/library/papers/42781078 | PubMed |
| 42736457 | Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42736457 | PubMed |
| 42731831 | PROspective Prostate Cancer Infrastructure: study protocol for the ProPCI 'trials within cohorts' study. | BMJ Open | 2026 | https://conductscience.org/library/papers/42731831 | PubMed |
| 42694552 | Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42694552 | PubMed |
| 42660995 | Deep learning augmented pathological grading and intraductal carcinoma of the prostate signatures improve recurrence prediction after intensity-modulated radiation therapy. | Virchows Arch | 2026 | https://conductscience.org/library/papers/42660995 | PubMed |
| 42652119 | ISUP Grade Group Migration Between Prostate Biopsy and Radical Prostatectomy: A Systematic Review of Emerging Predictors. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652119 | PubMed |
| 42642558 | Explainable artificial intelligence reveals key surgical parameters in robot-assisted and open radical prostatectomy. | Sci Rep | 2026 | https://conductscience.org/library/papers/42642558 | PubMed |
| 42638189 | Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/42638189 | PubMed |
| 42536276 | Impact of lymph node yield on biochemical recurrence in patients with high-risk prostate cancer after robot-assisted radical prostatectomy. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42536276 | PubMed |
| 42533777 | [18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer. | Int J Urol | 2026 | https://conductscience.org/library/papers/42533777 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9749478
GET https://conductscience.org/api/papers/v1/9749478/cited_by?page=2